Avatrombopag in Primary Immune Thrombocytopenia (ITP) in Adults
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This single-center study aims to study the efficacy and safety of avatrombopag in Chinese
adult ITP patients. This study will be conducted in adult ITP patients who had not responded
to eltrombopag or rhTPO in the previous treatment .